Detail page

Knowledge Web

Person

Uta Dirksen

Ärztin

Name	Uta Dirksen
Place	Deutschland
Academic degree	Dr. med.
Profession	Ärztin (characteristic profession)
Related	Universitätsklinikum Essen
Further information	Habil. Fach Kinderheilkunde **Stellvertretende Direktorin Kinderklinik III, Universitätsklinikum Essen
Source	Homepage: https://kinderklinik3.uk-essen.de/ueber-uns/team/ (Stand: 10.05.2024)
Record type	Person
GND-Identifier	115298789
Record ID	115298789
Involved in show all NUT carcinoma in pediatric patients: characteristics, therapeutic regimens, and outcomes of 11 cases registered with the German Registry for Rare Pediatric Tumors (STEP) Relevance of Abnormal KCNN1 Expression and Osmotic Hypersensitivity in Ewing Sarcoma Integrative gene network and functional analyses identify a prognostically relevant key regulator of metastasis in Ewing sarcoma Translational evidence for RRM2 as a prognostic biomarker and therapeutic target in Ewing sarcoma Localized angiosarcoma, not one disease: a retrospective single-center study on prognosis depending on the primary site and etiology No difference in survival after HLA mismatched versus HLA matched allogeneic stem cell transplantation in Ewing sarcoma patients with advanced disease Correction to: Assessment of treatment responses in children and adolescents with Ewing sarcoma with metabolic tumor parameters derived from 18F-FDG-PET/CT and circulating tumor DNA Combined inhibition of epigenetic readers and transcription initiation targets the EWS-ETS transcriptional program in Ewing sarcoma Fertility education for adolescent cancer patients: Gaps in current clinical practice in Europe Assessment of treatment responses in children and adolescents with Ewing sarcoma with metabolic tumor parameters derived from 18F-FDG-PET/CT and circulating tumor DNA Defining a Characteristic Gene Expression Set Responsible for Cancer Stem Cell-Like Features in a Sub-Population of Ewing Sarcoma Cells CADO-ES1 Focal adhesion kinase confers pro-migratory and antiapoptotic properties and is a potential therapeutic target in Ewing sarcoma Genetic variation in gonadal impairment in female survivors of childhood cancer: a PanCareLIFE study protocol The CXCR4 antagonist plerixafor (AMD3100) promotes proliferation of Ewing sarcoma cell lines in vitro and activates receptor tyrosine kinase signaling Array-based DNA-methylation profiling in sarcomas with small blue round cell histology provides valuable diagnostic information The CXCR4 antagonist plerixafor (AMD3100) promotes proliferation of Ewing sarcoma cell lines in vitro and activates receptor tyrosine kinase signaling Ewing sarcoma during follow-up : The value of a predefined imaging protocol including FDG-PET/CT for the detection of tumour recurrence Whole Lung Irradiation in Patients with Exclusively Pulmonary Metastases of Ewing Tumors : Toxicity Analysis and Treatment Results of the EICESS-92 Trial Ewing’s Tumors over the Age of 40 – a Retrospective Analysis of 47 Patients Treated According to the International Clinical Trials EICESS 92 and EURO-E.W.I.N.G. 99 Die Rolle des Granulozyten-Makrophagen-Wachstumsfaktors für die Pathogenese der Alveolarproteinose Die Rolle des Granulozyten-Makrophagen-Wachstumsfaktors für die Pathogenese der Alveolarproteinose Regulation der Zytokinproduktion humaner T-Lymphozyten über den adhäsionsvermittelten und den antigenvermittelten Aktivierungsweg

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Uta Dirksen

NUT carcinoma in pediatric patients: characteristics, therapeutic regimens, and outcomes of 11 cases registered with the German Registry for Rare Pediatric Tumors (STEP)

Relevance of Abnormal KCNN1 Expression and Osmotic Hypersensitivity in Ewing Sarcoma

Integrative gene network and functional analyses identify a prognostically relevant key regulator of metastasis in Ewing sarcoma

Translational evidence for RRM2 as a prognostic biomarker and therapeutic target in Ewing sarcoma

Localized angiosarcoma, not one disease: a retrospective single-center study on prognosis depending on the primary site and etiology

No difference in survival after HLA mismatched versus HLA matched allogeneic stem cell transplantation in Ewing sarcoma patients with advanced disease

Correction to: Assessment of treatment responses in children and adolescents with Ewing sarcoma with metabolic tumor parameters derived from 18F-FDG-PET/CT and circulating tumor DNA

Combined inhibition of epigenetic readers and transcription initiation targets the EWS-ETS transcriptional program in Ewing sarcoma

Fertility education for adolescent cancer patients: Gaps in current clinical practice in Europe

Assessment of treatment responses in children and adolescents with Ewing sarcoma with metabolic tumor parameters derived from 18F-FDG-PET/CT and circulating tumor DNA

Defining a Characteristic Gene Expression Set Responsible for Cancer Stem Cell-Like Features in a Sub-Population of Ewing Sarcoma Cells CADO-ES1

Focal adhesion kinase confers pro-migratory and antiapoptotic properties and is a potential therapeutic target in Ewing sarcoma

Genetic variation in gonadal impairment in female survivors of childhood cancer: a PanCareLIFE study protocol

The CXCR4 antagonist plerixafor (AMD3100) promotes proliferation of Ewing sarcoma cell lines in vitro and activates receptor tyrosine kinase signaling

Array-based DNA-methylation profiling in sarcomas with small blue round cell histology provides valuable diagnostic information

The CXCR4 antagonist plerixafor (AMD3100) promotes proliferation of Ewing sarcoma cell lines in vitro and activates receptor tyrosine kinase signaling

Ewing sarcoma during follow-up : The value of a predefined imaging protocol including FDG-PET/CT for the detection of tumour recurrence

Whole Lung Irradiation in Patients with Exclusively Pulmonary Metastases of Ewing Tumors : Toxicity Analysis and Treatment Results of the EICESS-92 Trial

Ewing’s Tumors over the Age of 40 – a Retrospective Analysis of 47 Patients Treated According to the International Clinical Trials EICESS 92 and EURO-E.W.I.N.G. 99

Die Rolle des Granulozyten-Makrophagen-Wachstumsfaktors für die Pathogenese der Alveolarproteinose

Die Rolle des Granulozyten-Makrophagen-Wachstumsfaktors für die Pathogenese der Alveolarproteinose

Regulation der Zytokinproduktion humaner T-Lymphozyten über den adhäsionsvermittelten und den antigenvermittelten Aktivierungsweg